Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ · Manufacturing · Pharmaceutical preparations
PHAT price, last 12 months
Key stats
- Previous close
- $5.30
- Open
- $5.20
- Day range
- $5.04 – $5.34
- 52-week range
- $4.56 – $18.31
- Volume
- 1M
- Avg volume (20 days)
- 1.9M
- Market cap
- $492.6M
Performance
Technicals and fundamentals
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $492.6M